ArticleCureus2025
Long-Term Outcomes and Survival in Patients Undergoing Multiple vs. Single Renal Artery Transplants: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The incidence of end-stage renal disease (ESRD) is increasing, and strategies are needed to expand the available kidney donor pool. Urologists have not preferred multiple renal artery (MRA) grafts due to concerns about higher complication rates. This study aimed to compare graft and patient survival post-transplant, complications, and the time taken to reach the nadir creatinine levels. Methods The records of 185 patients who had undergone renal transplants in a tertiary care center in Puducherry from 2012 to 2021 were collected and were divided into two groups: Single renal artery (SRA) graft recipients in group 1 and MRA graft recipients in group 2, and was further subdivided into deceased and live donor grafts, and further data were retrieved from the case sheets, master chart maintained by the Nephrology and Urology departments and Healthcare Information System (HIS) web portal. Results The mean age of group 1 was 33.54±10.44 and for group 2 it was 33.18±10.32 years, gender distribution and BMI of the two groups were also similar. The two-year graft survival for the SRA group was 76.06%, and for the MRA group was 81.25%. For the two years of patient survival, the SRA group had 85.43% survival and the MRA group had 81.25% survival. The creatinine returned to nadir level by day 5 to day 7 post-transplant for both groups. Also, the development of various complications in the post-transplant period was similar in both groups; however, the MRA group who underwent deceased donor transplants faced a higher risk of complications of the transplant operation. Conclusion This study demonstrates that kidney transplants using MRA grafts yield comparable outcomes to SRA grafts, despite challenges such as longer ischemia times and higher complication rates. Larger, multi-center studies are needed to further evaluate MRA grafts and optimize surgical approaches for broader donor inclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.